85 related articles for article (PubMed ID: 94316)
21. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch.
Treib J; Haass A; Pindur G; Grauer MT; Jung F; Wenzel E; Schimrigk K
Arzneimittelforschung; 1997 Jan; 47(1):18-22. PubMed ID: 9037438
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of infusion with hydroxyethyl starch and low molecular weight dextran on cerebral blood flow and hemorheology in normal baboons.
Tsuda Y; Hartmann A; Weiand J; Solymosi L
J Neurol Sci; 1987 Dec; 82(1-3):171-80. PubMed ID: 2450177
[TBL] [Abstract][Full Text] [Related]
23. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
[TBL] [Abstract][Full Text] [Related]
24. [Flow characteristics of blood and its therapeutic modification].
Reinhart WH
Schweiz Med Wochenschr; 1987 May; 117(18):693-7. PubMed ID: 3589626
[TBL] [Abstract][Full Text] [Related]
25. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
26. On the effect of microstructural changes of blood on energy dissipation in Couette flow.
Kaliviotis E; Yianneskis M
Clin Hemorheol Microcirc; 2008; 39(1-4):235-42. PubMed ID: 18503131
[TBL] [Abstract][Full Text] [Related]
27. [Rheologic findings in patients with diabetic retinopathy].
Bertram B; Wolf S; Kaufhold F; Jung F; Kiesewetter H; Reim M
Fortschr Ophthalmol; 1991; 88(4):321-5. PubMed ID: 1786912
[TBL] [Abstract][Full Text] [Related]
28. Detection of red cell aggregation by low shear rate viscometry in whole blood with elevated plasma viscosity.
Janzen J; Elliott TG; Carter CJ; Brooks DE
Biorheology; 2000; 37(3):225-37. PubMed ID: 11026942
[TBL] [Abstract][Full Text] [Related]
29. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
30. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
31. [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
Mishler JM; Beez M
Infusionsther Klin Ernahr; 1979 Apr; 6(2):119-22. PubMed ID: 85606
[TBL] [Abstract][Full Text] [Related]
32. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.
Ferber HP; Nitsch E; Förster H
Arzneimittelforschung; 1985; 35(3):615-22. PubMed ID: 2581591
[TBL] [Abstract][Full Text] [Related]
33. [Conjunctival oxygen partial pressure, hemorheology and circulatory parameters in acute cerebral infarct before and following infusion of 6 percent low molecular hydroxyethyl starch].
Kortsik CS; Staedt U; Stein T; Geiger G; Buss J
Infusionstherapie; 1990 Apr; 17(2):79-82. PubMed ID: 1693909
[TBL] [Abstract][Full Text] [Related]
34. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
35. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
Marotta F; Safran P; Tajiri H; Princess G; Anzulovic H; Idéo GM; Rouge A; Seal MG; Idéo G
Hepatogastroenterology; 2001; 48(38):511-7. PubMed ID: 11379344
[TBL] [Abstract][Full Text] [Related]
36. [Blood, plasma, erythrocyte viscosity and index of erythrocyte filtration in subjects with hyperlipemia].
Craveri A; Tornaghi G; Paganardi L; Lanfredini M; Citella C; Leonardi G
Minerva Med; 1987 Jun; 78(12):823-9. PubMed ID: 3601130
[TBL] [Abstract][Full Text] [Related]
37. Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation?
Morariu AM; Gu YJ; Huet RC; Siemons WA; Rakhorst G; Oeveren WV
Eur J Cardiothorac Surg; 2004 Nov; 26(5):939-46. PubMed ID: 15519186
[TBL] [Abstract][Full Text] [Related]
38. [Effect of Expafusion (HES 40/0.5) on the corpuscular elements of blood and inhibitors of blood coagulation].
Köstering H; Giffhorn J; Negendank-Damenz B
Infusionsther Klin Ernahr; 1985 Dec; 12(6):304-7. PubMed ID: 2419250
[TBL] [Abstract][Full Text] [Related]
39. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
40. Influence of a parenteral fish-oil preparation (Omegaven) on erythrocyte morphology and blood viscosity in vitro.
Fischler L; Meredith DO; Reinhart WH
Clin Hemorheol Microcirc; 2003; 28(2):79-88. PubMed ID: 12652013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
